[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]<\/p>\n
[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]Effective Date 11-July-2023<\/p>\n
<\/p>\n
Introduction<\/strong> <\/p>\n Information We Collect<\/strong> <\/p>\n In addition, we may gather information about you automatically through your use of the Site (e.g., your IP address and how you navigate our Site). To learn more about how we use these and your choices in relation to these tracking technologies, please refer to our Cookie Policy<\/a>.<\/p>\n <\/p>\n We may use or augment the personal data we have about you with information obtained from other sources, such as public databases, social media platforms and other third parties. For example, we may use such third-party information to confirm contact, to verify licensure of healthcare professionals or to better understand your interests by associating graphical and\/or industry information with the information you have provided.<\/p>\n <\/p>\n If you submit any personal data relating to other individuals to us, you represent that you have the authority to do so and to permit us to use the information in accordance with this Privacy Policy.<\/p>\n <\/p>\n <\/p>\n Use of Personal Data<\/strong><\/p>\n We will use the information that we collect about you for the following purposes:<\/p>\n <\/p>\n <\/p>\n We may provide functionality on the Site that will allow you to forward and share certain content with another person, or we may offer access to third party sharing functionality, such as third-party social media widgets\/tools\/buttons. If you choose to use our sharing functionality or a third party\u2019s sharing functionality to refer someone to our content or service, we will use both of your data to send the content or link you request. If you use that functionality, your use is subject to the third party\u2019s privacy policy and terms.<\/p>\n <\/p>\n We use the information you provide for data analysis, to better understand, track and respond to concerns, for fraud prevention, and to comply with our regulatory monitoring and reporting obligations. If we want to use your information for any other purpose, we will ask you for consent and will use your information only upon receiving your consent, and only for the purpose(s) for which your consent was granted for, unless we are required to do otherwise by law.<\/p>\n <\/p>\n How We Share Your Information <\/strong> <\/p>\n SFJ may share your personal data amongst and between the family of companies – subsidiaries and affiliates for the purposes listed in this Privacy Policy.<\/p>\n <\/p>\n SFJ may share your personal data with another company on a sell or transfer of whole or part of the business. In this case, SFJ will require the receiving company to use and protect your personal data consistent with this Privacy Policy. We may also share your personal data with companies that were part of SFJ family of companies to whom we provide services during a transition period following separation.<\/p>\n <\/p>\n We may employ, contract, and\/or collaborate with other companies and individuals to perform services with respect to products or services (collectively, \u201cProviders\u201d). These Providers may be given access to your personal data needed to perform their functions. The Providers may not use such data other than on our behalf or subject to contracts that protect the confidentiality of the data. Providers include customer service and contract service\/support providers, email and SMS vendors, data analytics firms, web hosting and development companies. Some Providers may collect personal data on our behalf on our Site or Services.<\/p>\n <\/p>\n Among other Providers, we share information with third-party partners such as Google Analytics for the purpose of tracking website performance, statistics, and analytics through cookies. Google Analytics collects device information, IP address, location data, browser data, and user activity while using the Service. If you wish to opt-out of Google Analytics, you may do so here.<\/a><\/p>\n <\/p>\n We reserve the right to disclose your personal data as required by law, when we believe disclosure is necessary or appropriate to comply with a regulatory requirement, judicial proceeding, court order, government request, or legal process served on us, or to protect the safety, rights, or property of our customers, the public, SFJ, or others.<\/p>\n <\/p>\n SFJ may also disclose aggregate or de-identified data that is not personally identifiable to third parties for any purpose.<\/p>\n <\/p>\n International Visitors<\/strong> <\/p>\n This notice also applies to individuals based in the EU where personal data about those individuals is processed by SFJ and who are participants in the following clinical trial:[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text css=”.vc_custom_1689986633052{padding-left: 60px !important;}”]<\/p>\n A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients with Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)<\/em><\/p>\n <\/p>\n Brief Summary:<\/u><\/p>\n <\/p>\n This is a multi-center, open-label, prospective single-arm study of reversal of the antiplatelet effects of ticagrelor with bentracimab (PB2452) in patients who present with uncontrolled major or life-threatening bleeding or who require urgent surgery or invasive procedure.<\/p>\n <\/p>\n At least 200 patients will be enrolled from approximately 200 centers in North America, Europe, and Asia-Pacific regions, including mainland China. Patients with reported use of ticagrelor within the prior 3 days who require urgent ticagrelor reversal will be eligible for enrollment. These populations will be enrolled based on separate inclusion criteria.\u00a0 For more information about the ongoing study, please visit Clinicaltrials.gov<\/a>:<\/p>\n <\/p>\n Phase 3 Study to Evaluate Bentracimab (PB2452) in Ticagrelor-treated Patients with Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT)<\/em><\/a><\/p>\n <\/p>\n
\nWelcome to the website, www.sfj-pharma.com<\/a> (the \u201cSite\u201d), of SFJ Pharmaceuticals, Inc. (\u201cSFJ\u201d, \u201cwe\u201d, \u201cus\u201d and\/or \u201cour\u201d). When we refer to \u201cSFJ,\u201d \u201cwe, \u201cus\u201d, and\/or \u201cour\u201d, we mean SFJ Pharmaceuticals Inc. and all its subsidiaries and affiliate companies. This Site is operated by SFJ and has been created to provide information about our company and our products and services (collectively, our \u201cServices\u201d) to our Site visitors (\u201cyou\u201d, \u201cyour\u201d). This Privacy Policy sets forth SFJ\u2019s policy with respect to information including personally identifiable data (\u201cPersonal Data\u201d) and other information that we collect from you; how we use that information; how protect it; and the choices you may have with respect to it.<\/p>\n
\nWe collect personal data you voluntarily provide through registrations, applications, clinical trial participation, and in connection with your inquiries. For example, you may choose to provide your name, contact information, in connection with a business contact, a patient inquiry, assistance or support program, or job application. Healthcare providers may choose to provide information relating to their specialties and professional affiliations. We may collect personal data through your use of our Services including in connection with managing clinical trials, conducting research, and tracking adverse events reports.<\/p>\n\n
\nWe will not transfer or sell your personal information to any third party without seeking your consent, except in limited circumstances as described below:<\/p>\n
\nThe Site is controlled and operated by us from the United States (\u201cU.S.\u201d) and is not intended to subject us to the laws or jurisdiction of any state, country or territory other than that of the United States. Any information you provide to SFJ through use of the Site may be stored and processed, transferred between and accessed from the United States and other countries which may not guarantee the same level of protection of personal data as the one in which you reside. However, SFJ will handle your personal data in accordance with this Privacy Policy regardless of where your personal data is stored and accessed. By providing any information, including personal information, on or through our Site, you consent to such transfer, storage, and processing.<\/p>\n